Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

被引:7
|
作者
Correale, Michele [1 ]
Tricarico, Lucia [1 ]
Croella, Francesca [2 ]
Alfieri, Simona [2 ]
Fioretti, Francesco [3 ]
Brunetti, Natale Daniele [2 ]
Inciardi, Riccardo M. [3 ]
Nodari, Savina [3 ]
机构
[1] Policlin Riuniti Univ Hosp, Dept Cardiothorac, Foggia, Italy
[2] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[3] Univ Brescia, ASST Spedali Civili Hosp, Dept Med & Surg Specialties, Cardiol Sect, Brescia, Italy
来源
关键词
new drugs; therapy targets; heart failure; cardiac metabolism; mitochondrial function; CGMP pathway; SOLUBLE GUANYLATE-CYCLASE; REDUCED EJECTION FRACTION; FATTY-ACID OXIDATION; LEFT-VENTRICULAR HYPERTROPHY; RANDOMIZED CONTROLLED-TRIAL; COTRANSPORTER; INHIBITION; DOUBLE-BLIND; METABOLIC MODULATOR; CLINICAL-TRIAL; NATRIURETIC PEPTIDE;
D O I
10.3389/fcvm.2023.1157472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite recent advances in chronic heart failure (HF) management, the prognosis of HF patients is poor. This highlights the need for researching new drugs targeting, beyond neurohumoral and hemodynamic modulation approach, such as cardiomyocyte metabolism, myocardial interstitium, intracellular regulation and NO-sGC pathway. In this review we report main novelties on new possible pharmacological targets for HF therapy, mainly on new drugs acting on cardiac metabolism, GCs-cGMP pathway, mitochondrial function and intracellular calcium dysregulation.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Editorial: Novelties in the Therapeutic Approaches for Chronic Heart Failure: Cardiovascular Targets and Beyond
    Sorgente, Antonio
    Passantino, Andrea
    Iacoviello, Massimo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [2] Editorial: Novelties in the therapeutic approaches for chronic heart failure: cardiovascular targets and beyond, volume II
    Iacoviello, Massimo
    Sorgente, Antonio
    Passantino, Andrea
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [3] Novelties in the pharmacological treatment of chronic heart failure
    Nyolczas Noemi
    ORVOSI HETILAP, 2016, 157 (38) : 1516 - 1520
  • [4] Pharmacological management of chronic heart failure: old drugs, new drugs and new indications
    Lim, Wei Yao
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (02) : C18 - C22
  • [5] Novelties in Therapy of Chronic Heart Failure
    Doimo, Sara
    Pavan, Daniela
    HEART FAILURE CLINICS, 2021, 17 (02) : 255 - 262
  • [6] Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction
    Moloce, Maria-Angela
    Costache, Irina-Iuliana
    Nicolae, Ana
    Onofrei Aursulesei, Viviana
    LIFE-BASEL, 2022, 12 (08):
  • [7] New pharmacological strategies in chronic heart failure
    van de Wal, RMA
    Voors, AA
    Plokker, HWM
    van Gilst, WH
    van Veldhuisen, DJ
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (06) : 491 - 501
  • [8] New Pharmacological Strategies in Chronic Heart Failure
    van de Wal Rma
    Voors AA
    Plokker HWM
    van Gilst WH
    van Veldhuisen DJ
    Cardiovascular Drugs and Therapy, 2004, 18 : 491 - 501
  • [9] Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure
    Lainscak, Mitja
    Vitale, Cristiana
    Seferovic, Petar
    Spoletini, Ilaria
    Trobec, Katja Cvan
    Rosano, Giuseppe M. C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 224 : 191 - 198
  • [10] New developments in the pharmacological treatment of chronic heart failure
    Krum, H
    Liew, D
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (05) : 751 - 757